[144] F5, Inc. SEC Filing
Form 144 notice indicates proposed sale of 1,300 common shares by an officer/person for whose account the securities are to be sold, to be executed through Morgan Stanley Smith Barney LLC on 09/02/2025 with an aggregate market value of $402,493.00. The filing shows the 1,300 shares were acquired as restricted stock on 02/01/2021 (589 shares) and 11/01/2022 (711 shares). The issuer’s outstanding shares are listed as 57,447,170. The filing also discloses two prior common-stock sales by the same person: 1,300 shares on 08/01/2025 for $400,582.00 and 1,300 shares on 07/01/2025 for $382,616.00. The signer represents they are not aware of undisclosed material adverse information and includes the standard criminal-misstatement warning.
Avviso Modulo 144 relativo alla proposta di vendita di 1.300 azioni ordinarie da parte di un dirigente/di una persona per conto della quale le azioni saranno vendute, da eseguirsi tramite Morgan Stanley Smith Barney LLC il 09/02/2025, con un valore di mercato complessivo di $402,493.00. La comunicazione indica che le 1.300 azioni sono state acquisite come azioni soggette a restrizioni in data 02/01/2021 (589 azioni) e 11/01/2022 (711 azioni). Le azioni in circolazione dell’emittente sono riportate come 57.447.170. La dichiarazione riporta inoltre due precedenti vendite di azioni ordinarie dalla medesima persona: 1.300 azioni il 08/01/2025 per $400,582.00 e 1.300 azioni il 07/01/2025 per $382,616.00. Il firmatario dichiara di non essere a conoscenza di informazioni materiali avverse non divulgate e include l’avviso standard relativo a dichiarazioni penali false.
Aviso del Formulario 144 que indica la propuesta de venta de 1.300 acciones ordinarias por parte de un ejecutivo/persona para cuya cuenta se venderán los valores, a ejecutarse a través de Morgan Stanley Smith Barney LLC el 09/02/2025, con un valor de mercado agregado de $402,493.00. La presentación muestra que las 1.300 acciones se adquirieron como acciones restringidas el 02/01/2021 (589 acciones) y el 11/01/2022 (711 acciones). Las acciones en circulación del emisor se listan como 57,447,170. La presentación también revela dos ventas anteriores de acciones ordinarias por la misma persona: 1.300 acciones el 08/01/2025 por $400,582.00 y 1.300 acciones el 07/01/2025 por $382,616.00. El firmante manifiesta no tener conocimiento de información material adversa no divulgada e incluye la advertencia penal estándar sobre declaraciones falsas.
양식 144 통지는 임원 또는 매각 대상 계정의 개인이 Morgan Stanley Smith Barney LLC를 통해 09/02/2025에 총액 $402,493.00 상당의 1,300 보통주 매각을 제안했음을 나타냅니다. 제출서류에 따르면 이 1,300주는 제한주로 02/01/2021(589주)와 11/01/2022(711주)에 취득된 것으로 기재되어 있습니다. 발행사의 유통 주식 수는 57,447,170로 기재되어 있습니다. 동일 인물의 이전 보통주 매각 두 건도 공개되어 있으며, 08/01/2025에 1,300주(금액 $400,582.00)와 07/01/2025에 1,300주(금액 $382,616.00)가 있습니다. 서명인은 공개되지 않은 중대한 불리한 정보가 없음을 진술하며 표준 형사 허위진술 경고를 포함합니다.
Avis du formulaire 144 indiquant la proposition de vente de 1 300 actions ordinaires par un dirigeant/une personne pour le compte de laquelle les titres doivent être vendus, à exécuter via Morgan Stanley Smith Barney LLC le 09/02/2025, pour une valeur marchande totale de $402,493.00. Le dépôt précise que les 1 300 actions ont été acquises en tant qu’actions restreintes le 02/01/2021 (589 actions) et le 11/01/2022 (711 actions). Le nombre d’actions en circulation de l’émetteur est indiqué comme 57,447,170. Le dossier divulgue également deux ventes antérieures d’actions ordinaires par la même personne : 1 300 actions le 08/01/2025 pour $400,582.00 et 1 300 actions le 07/01/2025 pour $382,616.00. Le signataire déclare ne pas avoir connaissance d’informations défavorables matérielles non divulguées et inclut l’avertissement pénal standard concernant les fausses déclarations.
Formular‑144‑Mitteilung weist auf den geplanten Verkauf von 1.300 Stammaktien durch einen Leitungsperson/ eine Person, in deren Namen die Wertpapiere verkauft werden sollen, hin. Die Ausführung soll über Morgan Stanley Smith Barney LLC am 09/02/2025 erfolgen, mit einem aggregierten Marktwert von $402,493.00. Die Einreichung zeigt, dass die 1.300 Aktien als Restricted Stock am 02/01/2021 (589 Aktien) und 11/01/2022 (711 Aktien) erworben wurden. Die ausstehenden Aktien des Emittenten werden mit 57.447.170 aufgeführt. Die Meldung legt außerdem zwei frühere Verkäufe derselben Person offen: 1.300 Aktien am 08/01/2025 für $400,582.00 und 1.300 Aktien am 07/01/2025 für $382,616.00. Der Unterzeichner gibt an, nichts von nicht offengelegten wesentlichen nachteiligen Informationen zu wissen, und fügt die übliche strafrechtliche Warnung vor Falschangaben bei.
- Complete disclosure of broker, share counts, acquisition dates, and aggregate market value
- Shows provenance of shares as restricted stock grants (2021 and 2022), clarifying the nature of holdings
- Includes prior sales for transparent transaction history
- Insider sales reported in July, August, and a proposed sale in September 2025, indicating ongoing dispositions
- Aggregate value disclosed ($402,493) represents a sale of shares rather than an acquisition
Insights
TL;DR: Routine Rule 144 disclosure of insider share sales and planned sale; provides transparency but does not itself state material company changes.
The filing documents a proposed sale under Rule 144 of 1,300 common shares through Morgan Stanley Smith Barney LLC and records prior sales in July and August 2025. Acquisition details show the shares originated from restricted stock awards in 2021 and 2022, consistent with typical post-vesting dispositions. The filer makes the required representation about absence of undisclosed material adverse information. From a compliance perspective the form appears to include required elements: broker, number of shares, aggregate value, acquisition dates and nature, and recent sales history.
TL;DR: Multiple near-term insider sales disclosed; the form provides clear trade cadence and provenance of shares.
The notice identifies Morgan Stanley as the executing broker and ties the sold shares to specific restricted stock grant dates and quantities (589 and 711). The presence of two prior monthly sales (July and August 2025) plus this proposed September sale shows a sequence of dispositions, and the filing quantifies proceeds for prior trades. The document is focused on disclosure of planned and past transactions rather than corporate operational matters; it enables investors and compliance teams to track insider selling activity.
Avviso Modulo 144 relativo alla proposta di vendita di 1.300 azioni ordinarie da parte di un dirigente/di una persona per conto della quale le azioni saranno vendute, da eseguirsi tramite Morgan Stanley Smith Barney LLC il 09/02/2025, con un valore di mercato complessivo di $402,493.00. La comunicazione indica che le 1.300 azioni sono state acquisite come azioni soggette a restrizioni in data 02/01/2021 (589 azioni) e 11/01/2022 (711 azioni). Le azioni in circolazione dell’emittente sono riportate come 57.447.170. La dichiarazione riporta inoltre due precedenti vendite di azioni ordinarie dalla medesima persona: 1.300 azioni il 08/01/2025 per $400,582.00 e 1.300 azioni il 07/01/2025 per $382,616.00. Il firmatario dichiara di non essere a conoscenza di informazioni materiali avverse non divulgate e include l’avviso standard relativo a dichiarazioni penali false.
Aviso del Formulario 144 que indica la propuesta de venta de 1.300 acciones ordinarias por parte de un ejecutivo/persona para cuya cuenta se venderán los valores, a ejecutarse a través de Morgan Stanley Smith Barney LLC el 09/02/2025, con un valor de mercado agregado de $402,493.00. La presentación muestra que las 1.300 acciones se adquirieron como acciones restringidas el 02/01/2021 (589 acciones) y el 11/01/2022 (711 acciones). Las acciones en circulación del emisor se listan como 57,447,170. La presentación también revela dos ventas anteriores de acciones ordinarias por la misma persona: 1.300 acciones el 08/01/2025 por $400,582.00 y 1.300 acciones el 07/01/2025 por $382,616.00. El firmante manifiesta no tener conocimiento de información material adversa no divulgada e incluye la advertencia penal estándar sobre declaraciones falsas.
양식 144 통지는 임원 또는 매각 대상 계정의 개인이 Morgan Stanley Smith Barney LLC를 통해 09/02/2025에 총액 $402,493.00 상당의 1,300 보통주 매각을 제안했음을 나타냅니다. 제출서류에 따르면 이 1,300주는 제한주로 02/01/2021(589주)와 11/01/2022(711주)에 취득된 것으로 기재되어 있습니다. 발행사의 유통 주식 수는 57,447,170로 기재되어 있습니다. 동일 인물의 이전 보통주 매각 두 건도 공개되어 있으며, 08/01/2025에 1,300주(금액 $400,582.00)와 07/01/2025에 1,300주(금액 $382,616.00)가 있습니다. 서명인은 공개되지 않은 중대한 불리한 정보가 없음을 진술하며 표준 형사 허위진술 경고를 포함합니다.
Avis du formulaire 144 indiquant la proposition de vente de 1 300 actions ordinaires par un dirigeant/une personne pour le compte de laquelle les titres doivent être vendus, à exécuter via Morgan Stanley Smith Barney LLC le 09/02/2025, pour une valeur marchande totale de $402,493.00. Le dépôt précise que les 1 300 actions ont été acquises en tant qu’actions restreintes le 02/01/2021 (589 actions) et le 11/01/2022 (711 actions). Le nombre d’actions en circulation de l’émetteur est indiqué comme 57,447,170. Le dossier divulgue également deux ventes antérieures d’actions ordinaires par la même personne : 1 300 actions le 08/01/2025 pour $400,582.00 et 1 300 actions le 07/01/2025 pour $382,616.00. Le signataire déclare ne pas avoir connaissance d’informations défavorables matérielles non divulguées et inclut l’avertissement pénal standard concernant les fausses déclarations.
Formular‑144‑Mitteilung weist auf den geplanten Verkauf von 1.300 Stammaktien durch einen Leitungsperson/ eine Person, in deren Namen die Wertpapiere verkauft werden sollen, hin. Die Ausführung soll über Morgan Stanley Smith Barney LLC am 09/02/2025 erfolgen, mit einem aggregierten Marktwert von $402,493.00. Die Einreichung zeigt, dass die 1.300 Aktien als Restricted Stock am 02/01/2021 (589 Aktien) und 11/01/2022 (711 Aktien) erworben wurden. Die ausstehenden Aktien des Emittenten werden mit 57.447.170 aufgeführt. Die Meldung legt außerdem zwei frühere Verkäufe derselben Person offen: 1.300 Aktien am 08/01/2025 für $400,582.00 und 1.300 Aktien am 07/01/2025 für $382,616.00. Der Unterzeichner gibt an, nichts von nicht offengelegten wesentlichen nachteiligen Informationen zu wissen, und fügt die übliche strafrechtliche Warnung vor Falschangaben bei.
FAQ
What does the Form 144 for FFIV report?
Who is the named seller and where are prior sales recorded?
How were the shares acquired?
What exchange and outstanding share count are listed?
Does the filing state any undisclosed material information?
